Despite Journey Medical's Pullback, Insiders Still Gained US$118k [Yahoo! Finance]
Journey Medical Corporation (DERM)
Last journey medical corporation earnings: 11/5 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.dermira.com
Company Research
Source: Yahoo! Finance
After accounting for the recent loss, the US$237.3k worth of shares they purchased is now worth US$355.6k, suggesting a good return on their investment. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. See our latest analysis for Journey Medical Over the last year, we can see that the biggest insider purchase was by Independent Director Justin Smith for US$104k worth of shares, at about US$3.47 per share. Even though the purchase was made at a significantly lower price than the recent price (US$5.08), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive. Over the last year, we can see that insiders have bought 70.00k shares worth US$237k. But insiders sold 17.57k shares worth US$91k. In the last twelve months there was more buying than selling
Show less
Read more
Impact Snapshot
Event Time:
DERM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DERM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DERM alerts
High impacting Journey Medical Corporation news events
Weekly update
A roundup of the hottest topics
DERM
News
- Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]Yahoo! Finance
- Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaGlobeNewswire
- Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology ConferenceGlobeNewswire
DERM
Earnings
- 11/12/24 - Beat
DERM
Sec Filings
- 11/12/24 - Form 10-Q
- 11/12/24 - Form 8-K
- 11/4/24 - Form 8-K
- DERM's page on the SEC website